<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">Lício Velloso</segment>
<segment id="2" parent="1002" relname="preparation">Licio</segment>
<segment id="3" parent="1003" relname="preparation">Augusto</segment>
<segment id="4" parent="1004" relname="preparation">Velloso</segment>
<segment id="5" parent="1004" relname="joint">is a Brazilian full professor of medicine at the University of Campinas .</segment>
<segment id="6" parent="1006" relname="preparation">Education</segment>
<segment id="7" parent="1006" relname="sequence">Lício Velloso obtained his MD degree in 1986 from the University of Campinas .</segment>
<segment id="8" parent="1010" relname="span">He then attended Uppsala University in Sweden</segment>
<segment id="9" parent="8" relname="elaboration">from which he graduated in 1993</segment>
<segment id="10" parent="1009" relname="sequence">and then served as a postdoc at the Mario Saad Lab , University of Campinas and at the Ron Kahn Lab , Harvard University in 1994 and 1995 respectively .</segment>
<segment id="11" parent="1009" relname="evidence">[ 1 ]</segment>
<segment id="12" parent="1014" relname="span">He also was postdoctoral fellow at the Joslin Diabetes Center</segment>
<segment id="13" parent="12" relname="evidence">[ 2 ]</segment>
<segment id="14" parent="1013" relname="joint">and is coordinator of the Obesity and Comorbidities Research Center at the University of Campinas .</segment>
<segment id="15" parent="1013" relname="evidence">[ 3 ]</segment>
<segment id="16" parent="1016" relname="preparation">Research</segment>
<segment id="17" parent="1017" relname="preparation">In 2001 he studied type 2 diabetes along with Claudio Teodoro de Souza , a back-then Ph.D. student at the Cell Signaling Laboratory .</segment>
<segment id="18" parent="1019" relname="attribution">Their study revealed</segment>
<segment id="19" parent="1019" relname="span">that the disease reoccurs</segment>
<segment id="20" parent="1020" relname="span">when pancreas fail to supply the peripheral need for insulin</segment>
<segment id="21" parent="20" relname="elaboration">that the body needs .</segment>
<segment id="22" parent="1023" relname="attribution">According to Lício Velloso ,</segment>
<segment id="23" parent="1024" relname="span">as long as the pancreas can produce insulin</segment>
<segment id="24" parent="23" relname="purpose">to maintain this need ,</segment>
<segment id="25" parent="1023" relname="same_unit">the blood glucose level remains stable - close to 80 , 90 , expected for a healthy person .</segment>
<segment id="26" parent="1026" relname="same_unit">But ,</segment>
<segment id="27" parent="1028" relname="circumstance">when it does fail ,</segment>
<segment id="28" parent="1028" relname="span">the glucose rises ,</segment>
<segment id="29" parent="28" relname="elaboration">which makes a patient dependent on insulin .</segment>
<segment id="30" parent="1030" relname="span">This dependency can result into hyperinsulinemic hypoglycemia ,</segment>
<segment id="31" parent="30" relname="attribution">according to Velloso .</segment>
<segment id="32" parent="1032" relname="preparation">Under Velloso &apos;s guidance ,</segment>
<segment id="33" parent="1033" relname="joint">Souza had studied alpha protein</segment>
<segment id="34" parent="1033" relname="joint">and injected it with an insulin-producing cell .</segment>
<segment id="35" parent="1036" relname="concession">While the result did n&apos;t yield a major breakthrough ,</segment>
<segment id="36" parent="1036" relname="span">it opened a possibility</segment>
<segment id="37" parent="1037" relname="span">of developing a drug</segment>
<segment id="38" parent="37" relname="elaboration">that would reduce the action of PPARGC1A .</segment>
<segment id="39" parent="1039" relname="span">During the trials ,</segment>
<segment id="40" parent="1041" relname="attribution">which the duo conducted revealed</segment>
<segment id="41" parent="1041" relname="span">that it does indeed reduces the production of alpha protein</segment>
<segment id="42" parent="41" relname="circumstance">while increases insulin production .</segment>
<segment id="43" parent="1044" relname="concession">Not only did it increase insulin production ,</segment>
<segment id="44" parent="1044" relname="span">but it also decrease diabetes occurrence .</segment>
<segment id="45" parent="44" relname="evidence">[ 4 ]</segment>
<segment id="46" parent="1038" relname="joint">For two years , he and Marciane Milanski , a nutritionist , had studied obesity in rats .</segment>
<segment id="47" parent="1048" relname="attribution">During the study , it was suggested</segment>
<segment id="48" parent="1048" relname="span">that it is possible to make brain control liver</segment>
<segment id="49" parent="48" relname="purpose">in order to maintain glycemic balance .</segment>
<segment id="50" parent="51" relname="circumstance">When it does happen ,</segment>
<segment id="51" parent="1050" relname="span">the hypothalamus becomes the main actor of this mechanism .</segment>
<segment id="52" parent="1053" relname="attribution">The research , along with his comment :</segment>
<segment id="53" parent="1053" relname="span">&quot; The mechanism</segment>
<segment id="54" parent="55" relname="attribution">described by this research shows</segment>
<segment id="55" parent="1054" relname="span">that control of high glucose in fasting is done , at least in part , by the hypothalamus .</segment>
<segment id="56" parent="1058" relname="span">This reinforces our suspicion</segment>
<segment id="57" parent="56" relname="elaboration">that the development of drugs with action in the central nervous system should be interesting for the treatment of diabetes &quot;</segment>
<segment id="58" parent="1057" relname="same_unit">were published in the American Journal of Deabetes in 2012 .</segment>
<segment id="59" parent="1057" relname="evidence">[ 5 ]</segment>
<segment id="60" parent="1059" relname="joint">From 2005 to 2007 he had studied human diet ,</segment>
<segment id="61" parent="1061" relname="span">and , according to him , the studies of various groups have shown</segment>
<segment id="62" parent="1063" relname="span">that a diet</segment>
<segment id="63" parent="1064" relname="joint">rich in simple carbohydrates , can also increase lipid levels in the blood</segment>
<segment id="64" parent="1064" relname="joint">and indirectly promote inflammation in the hypothalamus .</segment>
<segment id="65" parent="1063" relname="evidence">[ 3 ]</segment>
<segment id="66" parent="1066" relname="joint">In 2018 Lício Velloso studied hunger strikes</segment>
<segment id="67" parent="1067" relname="span">and divided them in three categories :</segment>
<segment id="68" parent="67" relname="elaboration">Absolute , total and partial .</segment>
<segment id="69" parent="1070" relname="attribution">During the study , he suggested</segment>
<segment id="70" parent="1071" relname="span">that people</segment>
<segment id="71" parent="70" relname="elaboration">who do partial hunger strikes could have more severe consequences</segment>
<segment id="72" parent="1072" relname="span">then those</segment>
<segment id="73" parent="72" relname="elaboration">that have the absolute one .</segment>
<segment id="74" parent="1074" relname="span">For example , in an absolute strike only kidneys and heart fails after 25 days of being on a strike ,</segment>
<segment id="75" parent="1075" relname="span">while strikers</segment>
<segment id="76" parent="75" relname="elaboration">who preferred partial ended up with liver complications within 40 to 50 days after the strike .</segment>
<segment id="77" parent="1077" relname="same_unit">In conclusion , what Dr. Velloso suggests</segment>
<segment id="78" parent="1078" relname="span">is that people</segment>
<segment id="79" parent="78" relname="elaboration">who have a weak heart should n&apos;t take too much liquid ,</segment>
<segment id="80" parent="1080" relname="span">otherwise it can lead to heart failure and even death .</segment>
<segment id="81" parent="80" relname="evidence">[ 6 ]</segment>
<segment id="82" parent="1082" relname="span">On October 30 , 2018 he appeared on an interview with Paulo Saldiva of Science and Health program of the Futura Chanel .</segment>
<segment id="83" parent="82" relname="evidence">[ 7 ]</segment>
<segment id="84" parent="1084" relname="preparation">Editorial work</segment>
<segment id="85" parent="1084" relname="span">He is a former member of the editorial board of Clinical Endocrinology and current member of the editorial board of International Journal of Obesity .</segment>
<segment id="86" parent="85" relname="evidence">[ 8 ]</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="span"/>
<group id="1003" type="span" parent="1002" relname="span"/>
<group id="1004" type="multinuc" parent="1003" relname="span"/>
<group id="1005" type="span" parent="1004" relname="joint"/>
<group id="1006" type="multinuc" parent="1005" relname="span"/>
<group id="1007" type="multinuc" parent="1006" relname="sequence"/>
<group id="1008" type="span" parent="1007" relname="joint"/>
<group id="1009" type="multinuc" parent="1008" relname="span"/>
<group id="1010" type="span" parent="1009" relname="sequence"/>
<group id="1012" type="span" parent="1007" relname="joint"/>
<group id="1013" type="multinuc" parent="1012" relname="span"/>
<group id="1014" type="span" parent="1013" relname="joint"/>
<group id="1015" type="span" parent="1007" relname="joint"/>
<group id="1016" type="span" parent="1015" relname="span"/>
<group id="1017" type="multinuc" parent="1016" relname="span"/>
<group id="1018" type="span" parent="1017" relname="joint"/>
<group id="1019" type="span" parent="1018" relname="span"/>
<group id="1020" type="span" parent="19" relname="circumstance"/>
<group id="1022" type="span" parent="1017" relname="joint"/>
<group id="1023" type="multinuc" parent="1022" relname="span"/>
<group id="1024" type="span" parent="1023" relname="same_unit"/>
<group id="1026" type="multinuc" parent="1017" relname="joint"/>
<group id="1027" type="span" parent="1026" relname="same_unit"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="multinuc" parent="1017" relname="joint"/>
<group id="1030" type="span" parent="1029" relname="sequence"/>
<group id="1031" type="span" parent="1029" relname="sequence"/>
<group id="1032" type="multinuc" parent="1031" relname="span"/>
<group id="1033" type="multinuc" parent="1032" relname="sequence"/>
<group id="1035" type="span" parent="1032" relname="sequence"/>
<group id="1036" type="span" parent="1035" relname="span"/>
<group id="1037" type="span" parent="36" relname="elaboration"/>
<group id="1038" type="multinuc" parent="1032" relname="sequence"/>
<group id="1039" type="span" parent="1038" relname="joint"/>
<group id="1040" type="span" parent="39" relname="elaboration"/>
<group id="1041" type="span" parent="1040" relname="span"/>
<group id="1043" type="span" parent="1038" relname="joint"/>
<group id="1044" type="span" parent="1043" relname="span"/>
<group id="1046" type="multinuc" parent="1038" relname="joint"/>
<group id="1047" type="span" parent="1046" relname="sequence"/>
<group id="1048" type="span" parent="1047" relname="span"/>
<group id="1050" type="span" parent="1046" relname="sequence"/>
<group id="1052" type="span" parent="1046" relname="sequence"/>
<group id="1053" type="span" parent="1052" relname="span"/>
<group id="1054" type="span" parent="53" relname="elaboration"/>
<group id="1056" type="span" parent="1046" relname="sequence"/>
<group id="1057" type="multinuc" parent="1056" relname="span"/>
<group id="1058" type="span" parent="1057" relname="same_unit"/>
<group id="1059" type="multinuc" parent="1046" relname="sequence"/>
<group id="1061" type="span" parent="1059" relname="joint"/>
<group id="1062" type="span" parent="61" relname="elaboration"/>
<group id="1063" type="span" parent="1062" relname="span"/>
<group id="1064" type="multinuc" parent="62" relname="elaboration"/>
<group id="1065" type="multinuc" parent="1059" relname="joint"/>
<group id="1066" type="multinuc" parent="1065" relname="sequence"/>
<group id="1067" type="span" parent="1066" relname="joint"/>
<group id="1068" type="span" parent="1065" relname="sequence"/>
<group id="1069" type="span" parent="1068" relname="span"/>
<group id="1070" type="multinuc" parent="1069" relname="span"/>
<group id="1071" type="span" parent="1070" relname="same_unit"/>
<group id="1072" type="span" parent="1070" relname="same_unit"/>
<group id="1073" type="multinuc" parent="1069" relname="elaboration"/>
<group id="1074" type="span" parent="1073" relname="sequence"/>
<group id="1075" type="span" parent="74" relname="circumstance"/>
<group id="1076" type="multinuc" parent="1073" relname="sequence"/>
<group id="1077" type="multinuc" parent="1076" relname="joint"/>
<group id="1078" type="span" parent="1077" relname="same_unit"/>
<group id="1079" type="multinuc" parent="1076" relname="joint"/>
<group id="1080" type="span" parent="1079" relname="joint"/>
<group id="1081" type="multinuc" parent="1079" relname="joint"/>
<group id="1082" type="span" parent="1081" relname="joint"/>
<group id="1083" type="span" parent="1081" relname="joint"/>
<group id="1084" type="span" parent="1083" relname="span"/>
	</body>
</rst>
